Press release
Explosive Growth Forecasted: AI in Clinical Trials Market Set to Surge to $6.55 Billion by 2030
The integration of artificial intelligence (AI) in clinical trials has been a game-changer in the healthcare industry, offering unprecedented efficiency, accuracy, and innovation in drug development and patient care. As we delve into 2024, the AI in clinical trials market continues to witness remarkable growth, driven by key trends and recent industry developments.
Download a Free sample copy of Report:https://www.marketdigits.com/request/sample/3813
Major vendors in the global AI in Clinical Trials Market are IBM Corporation, Exscientia, Saama Technologies, Unlearn.AI, Inc., BioSymetrics, Euretos, Trials.Ai, Insilico Medicine, Ardigen, Pharmaseal, Koninklijke Philips N.V., Intel, Numerate, AiCure, LLC, Envisagenics, NURITAs, BioAge Labs, Inc., Symphony AI., Median Technologies, Innoplexus, Antidote Technologies, Inc., GNS Healthcare, Koneksa Health, Halo Health Systems, and DEEP LENS AI. and Others
Key Points:
Enhanced Efficiency: AI streamlines various aspects of clinical trials, from patient recruitment and data analysis to predictive modeling and decision-making. By automating repetitive tasks and analyzing vast datasets, AI significantly reduces trial timelines and costs while improving overall productivity.
Personalized Medicine: AI enables the customization of treatment plans based on individual patient characteristics, such as genetic makeup, medical history, and lifestyle factors. This personalized approach enhances treatment efficacy and minimizes adverse effects, leading to better patient outcomes.
Data-driven Insights: With AI-powered analytics, researchers gain deeper insights from complex clinical data, uncovering hidden patterns, biomarkers, and therapeutic targets. These insights accelerate the discovery and development of novel drugs and therapies, addressing unmet medical needs and advancing medical science.
Real-world Evidence (RWE) Integration: AI facilitates the integration of real-world evidence into clinical trials, leveraging data from electronic health records, wearables, and patient-reported outcomes. By incorporating real-world insights, trials become more representative of diverse patient populations and clinical settings, enhancing the generalizability of findings.
Read More:https://www.marketdigits.com/ai-in-clinical-trials-market-1705303219
Major Segmentations Are Distributed as follows:
By Offering
Software
Phase I
Phase II
Phase III
Services
Phase I
Phase II
Phase III
By Technology
Deep Learning
Machine Learning
Other Machine Learning Technologies
Supervised Learning
Others
By Application
Cardiovascular diseases
Immunology disease
Infecstious disease
Metabolic diseases
Nuerological disease and condition
Oncology
Others
By End User
Contract research organizations
Pharmaceutical & biotechnology companies
Others
By Region
North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Rest of Latin America
Europe
UK
Germany
France
Italy
Spain
Russia
BENELUX
CIS & Russia
Nordics
Austria
Poland
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Thailand
Indonesia
Malaysia
Vietnam
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
South Africa
Nigeria
Egypt
Israel
Turkey
Rest of Middle East & Africa
Recent Developments
August 2023, Texas Tech University Health Sciences Center has partnered with Deep 6 AI to initiate an AI program focused on clinical trials. This collaboration aims to leverage artificial intelligence to enhance and streamline processes within the clinical trial domain.
January 2022, Exscientia (UK) and Sanofi (France) have joined forces in a strategic research collaboration to create a pipeline of precision-engineered medicines using Exscientia's comprehensive AI-driven platform. This partnership, which incorporates real patient samples, is geared towards expediting drug discovery and enhancing clinical success for improved healthcare outcomes.
Key Trends:
AI-driven Patient Recruitment: AI algorithms analyze patient data to identify eligible participants for clinical trials more efficiently. By matching patients with suitable trials based on demographics, medical history, and genetic profiles, AI accelerates recruitment processes and improves trial enrollment rates.
Predictive Analytics: Predictive modeling powered by AI forecasts patient responses to treatments, enabling researchers to optimize trial design and protocol development. By simulating various scenarios and outcomes, predictive analytics mitigate risks and enhance trial success rates.
Natural Language Processing (NLP): NLP technologies interpret unstructured clinical data from sources such as medical records, physician notes, and literature, extracting valuable insights for trial design and analysis. NLP enables researchers to analyze textual data at scale, facilitating literature reviews, adverse event detection, and protocol optimization.
Blockchain for Data Security: Blockchain technology ensures the integrity and security of clinical trial data by providing immutable and transparent records of transactions and data exchanges. By enhancing data privacy, integrity, and traceability, blockchain solutions foster trust among stakeholders and regulatory bodies, accelerating the adoption of AI in clinical trials.
Recent 2024 Industry News:
FDA Guidelines on AI Adoption: In response to the growing use of AI in healthcare, the U.S. Food and Drug Administration (FDA) released updated guidelines outlining regulatory considerations for AI-based medical devices and software. The guidelines provide clarity on validation, transparency, and risk management requirements, fostering innovation while ensuring patient safety and data integrity.
Partnerships and Collaborations: Leading pharmaceutical companies, technology firms, and research institutions continue to forge partnerships to harness the potential of AI in clinical trials. Collaborative efforts aim to combine domain expertise with AI capabilities, accelerating drug discovery, and development processes while addressing healthcare challenges more effectively.
Investment and Funding: The AI in clinical trials market attracts significant investment and funding from venture capital firms, government agencies, and corporate entities. Funding supports the development of AI-driven platforms, tools, and solutions, fueling innovation and market growth.
Expansion of AI Applications: Beyond drug development, AI finds applications in various aspects of healthcare, including disease diagnosis, patient monitoring, and treatment optimization. As AI technologies mature, their integration into clinical practice becomes increasingly widespread, transforming healthcare delivery and patient outcomes.
Get this report at a discount:https://www.marketdigits.com/request/discount/3813
In conclusion, the AI in clinical trials market continues to evolve rapidly, driven by technological advancements, regulatory developments, and industry collaborations. As AI becomes increasingly ingrained in healthcare research and practice, its transformative impact on clinical trials promises to revolutionize the way we develop and deliver medical treatments, ultimately benefiting patients worldwide.
Contact Us:
1248 CarMia Way Richmond,
VA 23235, United States.
Phone: +1 510-730-3200
Email: sales@marketdigits.com
Website: https://www.marketdigits.com
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Explosive Growth Forecasted: AI in Clinical Trials Market Set to Surge to $6.55 Billion by 2030 here
News-ID: 3479103 • Views: …
More Releases from MarketDigits
Transforming Data Streams: Trends Shaping the IoT Analytics Market
The Internet of Things (IoT) analytics market is experiencing substantial growth, driven by the proliferation of connected devices, advancements in data analytics technologies, and the increasing need for actionable insights from IoT-generated data. IoT analytics refers to the process of collecting, analyzing, and interpreting data from connected devices to extract valuable insights for business decision-making, operational optimization, and predictive maintenance. IoT Analytics market was valued USD 29 Billion in 2023…
Shaping the Future: Trends in the Interactive Robot Market
Interactive robots, also known as social robots or companion robots, are intelligent machines designed to interact and communicate with humans in a social and intuitive manner. These robots are equipped with sensors, cameras, voice recognition, and natural language processing capabilities, allowing them to perceive their environment, understand human commands, and respond with appropriate actions. The global interactive robot market is witnessing rapid growth driven by advancements in artificial intelligence (AI),…
Greener Tomorrow: Trends in the Carbon Offset/Carbon Credit Market
The carbon offset or carbon credit market has gained significant traction in recent years as part of global efforts to combat climate change and reduce greenhouse gas emissions. Carbon offsets and credits allow organizations and individuals to compensate for their carbon footprint by investing in projects that reduce or capture emissions elsewhere. This overview will provide insights into key points, trends, and recent industry news shaping the carbon offset market.…
Chewable Health: Trends in the Gummy Vitamins Market
The gummy vitamins market has experienced significant growth over the past decade, driven by consumer demand for more palatable and convenient dietary supplements. Gummy vitamins, which are chewable and often fruit-flavored, appeal to both adults and children, particularly those who dislike traditional pill or tablet forms of supplements. These vitamins provide essential nutrients such as vitamins A, C, D, E, B-complex, and minerals like calcium, iron, and zinc, addressing nutritional…
More Releases for Trials
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction
According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to…
Growing Demand for Paper-Less Clinical Trials to Drive Global eCOA, eSource & Cl …
The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.
Click here to Get Synopsis…
CardioSecur introduces 3D-ECG for virtual trials at Clinical Trials Europe
The German MedTech company will present its mobile 3D-ECG solutions and how they can help to make virtual clinical trials more dynamic and cost efficient.
Barcelona, November 2019. CardioSecur’s 3D 22-lead ECG technology and its patient-centric ecosystem can revolutionize virtual trials. This is why the Frankfurt-based MedTech company will attend the conference for the first time. Clinical Trials Europe conference, previously known as Partnerships in Clinical Trials, has a successful track…
Tardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Resul …
Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs which are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities in the area of the brain known as the striatum.
Download the sample report @ https://www.pharmaproff.com/request-sample/1106
The reasons that some people who take these drugs may get TD, and some people do not, is…
Chronic Bronchitis Global Clinical Trials Market Analysis, Clinical Trials by Ph …
This research report titled “Chronic Bronchitis Global Clinical Trials Review, H2, 2018” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Chronic Bronchitis during the period 2018. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about…
Global Carotid Artery Stenosis, Clinical Trials Review, Clinical Trials by End P …
Market Research Hub (MRH) has actively included a new research study titled Carotid Artery Stenosis Global Clinical Trials Review, H2, 2018 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period 2018. In addition, a…
